ICAHN CARL C - 19 Dec 2024 SCHEDULE 13D/A Report for ENZON PHARMACEUTICALS INC Common Stock, No par value (ENZN)

Filing Manager
ICAHN CARL C
Reporting Manager
CARL C ICAHN
Security
ENZON PHARMACEUTICALS INC Common Stock, No par value
Symbol
ENZN
Shares outstanding
74,190,609 shares
Disclosed Ownership
36,056,636 shares
Ownership
48.6%
Form type
SCHEDULE 13D/A
Filing time
19 Dec 2024, 16:30:40 UTC
Date of event
19 Dec 2024
Next filing
23 Jun 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
CARL C ICAHN 48.6% 36,056,636 0 36,056,636 /s/ CARL C. ICAHN CARL C. ICAHN 0000921669
ICAHN PARTNERS MASTER FUND LP 20.1% 14,923,911 14,923,911 0 /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 0001322827
Icahn Offshore LP 20.1% 14,923,911 0 14,923,911 /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 0001322825
Icahn Partners LP 28.5% 21,132,725 21,132,725 0 /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 0001313666
Icahn Onshore LP 28.5% 21,132,725 0 21,132,725 /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 0001322826
Icahn Capital LP 48.6% 36,056,636 0 36,056,636 /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 0001412093
IPH GP LLC 48.6% 36,056,636 0 36,056,636 /s/ Ted Papapostolou Ted Papapostolou / Chief Financial Officer 0001412091
ICAHN ENTERPRISES HOLDINGS L.P. 48.6% 36,056,636 0 36,056,636 /s/ Ted Papapostolou Ted Papapostolou / Chief Financial Officer 0001034563
ICAHN ENTERPRISES G.P. INC. 48.6% 36,056,636 0 36,056,636 /s/ Ted Papapostolou Ted Papapostolou / Chief Financial Officer 0001257324
BECKTON CORP 48.6% 36,056,636 0 36,056,636 /s/ Ted Papapostolou Ted Papapostolou / Vice President 0001080113